Ginsenosides: A Potential Neuroprotective Agent

被引:103
作者
Zheng, Mengmeng [1 ]
Xin, Yizhou [2 ]
Li, Yujuan [1 ]
Xu, Fangxue [1 ]
Xi, Xiaozhi [1 ]
Guo, Hong [1 ]
Cui, Xiaowei [1 ]
Cao, Hui [1 ]
Zhang, Xi [1 ]
Han, Chunchao [1 ]
机构
[1] Shandong Univ Tradit Chinese Med, Sch Pharm, Jinan 250355, Shandong, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan 250011, Shandong, Peoples R China
关键词
CEREBRAL-ISCHEMIA-REPERFUSION; ALZHEIMERS-DISEASE; RAT MODEL; PARKINSONS-DISEASE; SIGNALING PATHWAY; MEMORY IMPAIRMENT; PANAX-GINSENG; MOUSE MODEL; ISCHEMIA/REPERFUSION INJURY; CARDIOVASCULAR-DISEASES;
D O I
10.1155/2018/8174345
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Ginseng is a traditional Chinese medicine with a wide range of pharmacological activities. Ginsenosides are the major constituents of ginseng. Ginsenosides have the unique biological activity and medicinal value, such as antitumor, anti-inflammatory, antioxidation, and inhibition of cell apoptosis. With the increase of stress in life, the incidence of nervous system diseases is also increasing. Neurological diseases pose a huge burden on people's life and health. In recent years, some studies have shown that ginsenosides have a certain role in the prevention and treatment of neurological diseases. However, the research is still in its infancy, and the relevant mechanisms are complex. In the paper, we review the effects and mechanisms of ginsenosides on epilepsy, depression, cerebral ischemia reperfusion injury, Alzheimer's disease, and Parkinson's disease. We hope to provide a theoretical basis for the treatment of nervous system diseases by ginsenosides.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury
    Bader, Miaad
    Li, Yazhou
    Tweedie, David
    Shlobin, Nathan A.
    Bernstein, Adi
    Rubovitch, Vardit
    Tovar-y-Romo, Luis B.
    DiMarchi, Richard D.
    Hoffer, Barry J.
    Greig, Nigel H.
    Pick, Chaim G.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 7
  • [32] Neuroprotective effects of ginsenosides on neural progenitor cells against oxidative injury
    Ye, Jun
    Yao, Jian-Ping
    Wang, Xu
    Zheng, Minying
    Li, Peng
    He, Chengwei
    Wan, Jian-Bo
    Yao, Xiaoli
    Su, Huanxing
    MOLECULAR MEDICINE REPORTS, 2016, 13 (04) : 3083 - 3091
  • [33] Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease-Viewpoint
    Sportelli, Carolina
    Urso, Daniele
    Jenner, Peter
    Chaudhuri, K. Ray
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [34] Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: a patent review
    Rajabian, Arezoo
    Rameshrad, Maryam
    Hosseinzadeh, Hossein
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 29 (01) : 55 - 72
  • [35] Ginseng and ginsenosides: Therapeutic potential for sarcopenia
    Zha, Weiwei
    Sun, Yuanhai
    Gong, Wenwen
    Li, Linghuan
    Kim, Wonnam
    Li, Hanbing
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [36] Neuroprotective Potential of Biflavone Ginkgetin: A Review
    Cankaya, I. Irem Tatli
    Devkota, Hari Prasad
    Zengin, Gokhan
    Samec, Dunja
    LIFE-BASEL, 2023, 13 (02):
  • [37] The neuroprotective potential of carotenoids in vitro and in vivo
    Manochkumar, Janani
    Doss, C. George Priya
    El-Seedi, Hesham R.
    Efferth, Thomas
    Ramamoorthy, Siva
    PHYTOMEDICINE, 2021, 91
  • [38] Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis
    Jiang, Mingchun
    Chi, Jiaxin
    Qiao, Yifan
    Wang, Jinpeng
    Zhang, Zhixin
    Liu, Jia
    Sheng, Xinhao
    Yuan, Liangjie
    PHARMACOLOGICAL RESEARCH, 2025, 212
  • [39] Neuroprotective Potential of Secondary Metabolites from Melicope lunu-ankenda (Rutaceae)
    Mohamed, Zeinab Abdulwanis
    Eliaser, Enas Mohamed
    Mazzon, Emanuela
    Rollin, Patrick
    Ee, Gwendoline Cheng Lian
    Razis, Ahmad Faizal Abdull
    MOLECULES, 2019, 24 (17):
  • [40] Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders
    Paudel, Yam Nath
    Angelopoulou, Efthalia
    Semple, Bridgette
    Piperi, Christina
    Othman, Iekhsan
    Shaikh, Mohd Farooq
    ACS CHEMICAL NEUROSCIENCE, 2020, 11 (04): : 485 - 500